MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuoustesting both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.

AI/ML

Biotechnology

Health Care

Health Data

MultiplAI Health

MultiplAI Health's headquarters in London, United Kingdom

Description

People (2)

Carlos Luzzani

Mark Ramondt

Jobs